Ampersand Capital Partners Invests In Syft Technologies, Leading Sift-Ms Solutions Provider
Apr 18, 2022•about 3 years ago
Description
Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today announced a minority investment in Syft Technologies Limited, a world leading provider of Mass Spectrometry (SIFT-MS) solutions. Ampersand's investment will allow Syft to accelerate their progress in the semiconductor market and develop the next scalable opportunity in life sciences.